Medical and surgical therapy of the cystine stone patient

Current Opinion in Urology

Volumn 11, Issue 4, 2001, Pages 353-358

  Ng, Christopher S ^a   Streem, Stevan B ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE;

AMINO ACID TRANSPORT; CYSTINURIA; HUMAN; KIDNEY TUBULE ABSORPTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; STONE ANALYSIS; UROLITHIASIS;

CYSTINE; GENOTYPE; HUMANS; LITHOTRIPSY; NEPHROSTOMY, PERCUTANEOUS; PHENOTYPE; URETEROSCOPY; URINARY CALCULI;

EID: 0034948873     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-200107000-00003     Document Type: Review

References (41)

1. Ambulatory evaluation of nephrolithiasis: An update of a 1980 protocol
2. The molecular basis of cystinuria: An update
3. Identification of five novel SLC3A1 (rBAT) gene mutations in Japanese cystinuria
4. Phenotypes and genotypes in cystinuria
5. Cystinuda: Genetic heterogeneity and allelism
6. Heterozygous cystinuria and urinary lithiasis
7. Renal polyamine excretion, tubular amino acid reabsorption and molecular genetics in cystinuria
8. Cloning and chromosomal localization of a human kidney cDNA involved in cystine, dibasic, and neutral amino acid transport
9. Localization, by linkage analysis, of the cystinuria type III gene to chromosome 19q13.1
10. Linkage of type II and type III cystinuria to 19q13.1: Codominant inheritance of two cystinuric alleles at 19q13.1 produces an extreme stone-forming phenotype
11. Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT. International Cystinuria Consortium
12. Cystinuria subtype and the risk of nephrolithiasis
13. Association between M467T and 114 C→A variants within the SLC3A1 gene and some phenotypical traits in cystinuria patients from Spain
14. Contemporary management of cystinuria
15. Medical treatment of cystinuria: Results of contemporary clinical practice
16. Medical treatment of cystinuria: Critical reappraisal of long-term results
17. Cystine calculi: Diagnosis and management
18. Cystinuria
19. Anticystinuric effects of glutamine and of dietary sodium restriction
20. Dietary restriction of sodium as a means of reducing urinary cystine
21. Stone dissolution with D-penicillamine in cystinuria
22. The use of D-penicillamine in cystinuria: Efficacy and untoward reactions
23. Comparison of 2-mercaptopropionylglycine and D-penicillamine in the treatment of cystinuria
24. Management of cystine nephrolithiasis with alpha-mercaptopropionylglycine
25. Effect of captopril on urinary cystine excretion in homozygous cystinuria
26. Clinical effect of captopril on the formation and growth of cystine calculi
27. Stone fragility - A new therapeutic distinction
28. Long-term followup in patients with cystine urinary calculi treated by percutaneous ultrasonic lithotripsy
29. Endourological experience with cystine calculi and a treatment algorithm
30. Contemporary urological intervention for cystinuric patients: Immediate and long-term impact and implications
31. An evaluation of ureteral laser lithotripsy: 225 consecutive patients
32. Photosensitization of cystine stones to induce laser lithotripsy
33. Use of Swiss Lithoclast for percutaneous nephrolithotripsy
34. Intracorporeal lithotripsy with the Swiss Lithoclast
35. Experience with the holmium laser as an endoscopic lithotrite
36. Intracorporeal lithotripsy with the holmium:YAG laser
37. Retrograde renoscopic fragmentation of moderate-size (1.5-3.0-cm) renal cystine stones
38. Dissolution of cystine calculi by irrigation with acetylcysteine through percutaneous nephrostomy
39. Chemolysis of cystine calculi
40. Improving cystine stone therapy: An in vitro study of dissolution